Last C$1.15 CAD
Change Today -0.11 / -8.73%
Volume 48.8K
BLU On Other Exchanges
Symbol
Exchange
Toronto
OTC US
Frankfurt
As of 5:00 PM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Roberto Bellini

Chief Executive Officer, President and Director, BELLUS Health Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 2 different industries.

See Board Relationships
34C$493,651
As of Fiscal Year 2013

Background*

Mr. Roberto Bellini has been the Chief Executive Officer and President of BELLUS Health Inc, since January 1, 2010. Mr. Bellini served as an Executive Vice President of Picchio Pharma Inc. until January 1, 2010. He served as a Vice President of Business Development at BELLUS Health Inc. from June 04, 2009 to January 01, 2010. He has been a Director of BELLUS Health Inc. since 2009. Mr. Bellini served as a Director of Thallion Pharmaceuticals, Inc., from March 2007 to ...

Read Full Background

Corporate Headquarters*

275 Armand-Frappier Boulevard
Laval, Quebec H7V 4A7

Canada

Phone: 450-680-4500
Fax: 450-680-4501

Board Members Memberships*

2007-2013
Former Independent Director, Chairman of Corporate Governance & Nominating Committee, Member of Compensation Committee and Member of Audit Committee
2009-Present
Chief Executive Officer, President and Director

Education*

BS
McGill University

Other Affiliations*

Annual Compensation*

SalaryC$315,857
Total Annual CompensationC$315,857

Stock Options*

All Other CompensationC$27,762
Total Number of Options1,642,230

Total Compensation*

Total Annual Cash CompensationC$493,651
Total Short Term CompensationC$315,857
Other Long Term CompensationC$27,762
Total Calculated CompensationC$493,651
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BLU:CN C$1.15 CAD -0.11

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.1M
Robert H. Gundel Ph.D., M.B.A.Chief Executive Officer, President, Director and Member of Financing Committee
Amorfix Life Sciences Ltd.
C$283.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BELLUS HEALTH INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.